Are there restrictions on the use of live attenuated influenza vaccine (LAIV) in health care workers?
LAIV transmission from a recently vaccinated person causing clinically important illness in an immunocompromised contact has not been reported. The rationale for avoiding use of LAIV among health care workers caring for such patients is the theoretic risk that a live, attenuated vaccine virus could be transmitted to the severely immunosuppressed person. As a precautionary measure, health care workers who receive LAIV should avoid providing care for severely immunosuppressed patients (i.e., hemopoetic stemm cell transplant recipients) for 7 days after vaccination.
